Historically, submissions have spiked at pre-election meetings as companies rush to avoid the process delays associated with an election, including the listing pauses during the official caretaker period. Officials have previously managed these spikes by adjusting the process.
This has happened before, there was consultation, and it was managed without harming patients
October 23, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Sandoz earns workplace recognition amid push for medicine access
August 28, 2026 - - Latest News -
Mayne Pharma bets on women’s health and direct distribution after a difficult year
August 28, 2026 - - Latest News -
Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients
August 28, 2026 - - Latest News -
Weight loss medicines drive revenue growth for Sigma and Wesfarmers Health
August 28, 2026 - - BioPharma -
Patients Australia puts healthcare’s quiet achievers in the spotlight
August 28, 2026 - - Latest News -
Cathy Freeman to headline 2026 Patient’s Choice Awards
August 27, 2026 - - Latest News -
Australian company secures Mitsubishi partnership to bring BioPQQ to market
August 26, 2026 - - Latest News
